期刊文献+

红细胞膜包载粉防己碱PLGA纳米粒的制备与体外评价 被引量:5

Preparation and in vitro evaluation of erythrocyte membrane-camouflaged tetrandrine-loaded PLGA nanoparticles
下载PDF
导出
摘要 目的制备红细胞膜包载粉防己碱PLGA纳米粒(RPTNs),并进行体外评价。方法采用乳化溶剂挥发法制备粉防己碱PLGA纳米粒(PTNs);单因素考察了PLGA的质量浓度、有机相体积、稳定剂浓度;优化了红细胞膜囊泡(RVs)和RPTNs的制备方法;对纳米粒的粒径、PDI、电位、包封率、形态和稳定性进行了表征;透析法考察了PTNs和RPTNs的体外释放特性;CCK-8法考察了该载药系统的体外细胞毒性。结果最佳制备工艺为:PLGA质量浓度20 g·L-1,稳定剂质量浓度10 g·L-1,油水体积比1∶20,RVs的制备采用超声合并挤压法;制备的PTNs形状圆整,粒径为(147.9±0.25) nm,PDI<0.15,包封率为(84.1±0.41)%,在30 d内保持稳定;RPTNs具有清晰的壳-核双层结构,粒径为(164.1±1.65) nm,PDI<0.2,在15 d内保持稳定;体外释放实验显示PTNs和RPTNs在120 h内对粉防止碱(tetrandrine,TET)均有缓释作用,且RPTNs平均累计释放量减少了5.33%;体外细胞毒性实验表明在正常细胞和肿瘤细胞中,RPTNs的IC50值均高于游离TET组和PTNs组,且对293T细胞的IC50值高于对MCF-7的IC50值。结论采用该制备方法得到的纳米粒包封率高、稳定性好,能显著延缓药物的释放,降低体外细胞毒性,增强对肿瘤细胞的抑制作用。 Objective To prepare the erythrocyte membrane-camouflaged tetrandrine-loaded PLGA nanoparticles(RPTNs) and investigate their characterization,stability,release and cytotoxicity in vitro.Methods Methods The tetrandrine-loaded PLGA nanoparticles(PTNs) were prepared by emulsification method.Three factors including PLGA concentration,oil phase volume,stabilizer concentration were investigated.Then the preparation methods of erythrocyte membrane vesicles(RVs) and RPTNs were optimized,and the particle size,polydispersity index(PDI),potential,encapsulation efficiency,morphology and stability of the nanoparticles were characterized.The release characteristic of PTNs and RPTNs were investigated by dialysis method.Furthermore,the CCK-8 kit assay was used to investigate the cytotoxicity of RPTNs.Results Optimal preparation technology was as follows:PLGA concentration was 20 g·L-1,stabilizer concentration was 10 g·L-1,oil-water phase ratio was 1∶20 and RVs was prepared by ultrasonic combined extrusion method.The PTNs had the spherical structure and kept their basic structure within 30 days.The average particle size was(147.9±0.25) nm,PDI was less than 0.15 and entrapment efficiency was(84.1±0.41)%.RPTNs showed shell-core double-layer structure and kept their basic structure within 15 days.The average size was(164.1±1.65)nm,PDI was less than 0.2.In vitro release test showed that both PTNs and RPTNs showed obvious sustained release effect within 120 h,and the release effect of RPTNs was reduced by 5.33%.in vitro cytotoxicity experiments showed that the IC50 of RPTNs was higher than that of the PTNs and free TET both in normal cells and tumor cells.And the IC50 of RPTNs in 293 T cells was significantly higher than that in MCF-7 cells.Conclusion The RPTNs prepared by the optimal method have a high encapsulation efficiency,good stability,sustained releasecharacteristic.They can significantly reduce the cytotoxicity of the free drug and passively enhance the inhibitory effect in tumor cells.
作者 阙晓 高明 郭朋程 连雨玫 苏靖 邱明丰 QUE Xiao;GAO Ming;GUO Pengcheng;LIAN Yumei;SU Jing;QIU Mingfeng(School of Pharmacy,Shanghai Jiao Tong University , Shanghai 200240,China;Shanghai Biomedical Science and Technology Industry Promotion Center,Shanghai 2QY1Q3,China)
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2020年第5期401-407,共7页 Journal of Shenyang Pharmaceutical University
基金 国家重大新药创制科技重大专项(2018ZX09711003-008-002) 国家自然科学基金资助项目(81573617) 上海市科学技术委员会资助项目(18ZR1419700)。
关键词 红细胞膜 粉防己碱 PLGA纳米粒 体外释放 细胞毒性 erythrocyte membrane tetrandrine PLGA nanoparticles drug release cytotoxicity
  • 相关文献

参考文献2

二级参考文献23

  • 1黄贤生,王东明.粉防己碱对兔髂动脉血管内皮细胞损伤致血管狭窄的干预作用[J].中国临床康复,2004,8(27):5815-5817. 被引量:5
  • 2段世英,王裕勤,孙圣斌,冯义柏.粉防己碱对缺血心脏去甲肾上腺素释放及代谢的影响[J].华中医学杂志,2005,29(3):201-202. 被引量:4
  • 3黄波,冯义柏,朱福,王毅,胡春燕,蒋庆渊,李锦玉,陆铭.粉防己碱对兔实验性动脉粥样硬化形成的影响[J].中国临床药学杂志,2005,14(5):294-297. 被引量:5
  • 4REDDY L H,ARIAS J L,COUVREUR P,et al. Magnetic nanop- articles: Design and characterization, toxicity and bi~ompatibili- ty, pharmaceutical and biomedical applications [ J ]. Chem Rev, 2012, 112 (11) :5818-5878.
  • 5PANKURST Q A, CONNOLLY J, DOBSON J, et al. Applica- tions of magnetic nanoparticles in biomedicine [ J ]. J Physics D: Appl Physics, 2003, 36:167-18l.
  • 6CORCHERO J L, VILLAVERDE A. Biomedical applications of distally controlled magnetic nanoparticles[ J]. Trends Bi~technol, 2009, 27(8) : 468-476.
  • 7ITO A, SHINKAI M, KOBAYASHI T, et al. Medical applica- tion of functionalized magnetic nanoparticles [ J ]. J Biosci Bio- eng, 2005,100(1) : 1-11.
  • 8KUMAR C S, MOHAMMAD F. Magnetic nanomaterials for hy- perthermia-based therapy and controlled drug delivery [ J ]. Adv Drug Deliv Rev, 2011, 63 ( 9 ) : 789 -808.
  • 9MALVAND[ A M, HADDAD F, MOQHIMI A. Acute restraint stre~ increases the frequency of vinblastine-induced micronuclei in mouse bone marrow cells[J]. Stress, 2010, 13 (3) :276- 280.
  • 10DANHIER F, ANSORENA E, PR~AT V, et al. PLGA-Based nanoparticles: An overview of biomedical applications [ J ]. J Controlled Release,2012, 161 (2) : 505-522.

共引文献19

同被引文献61

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部